Association of nephrotoxic medication exposure and nephrotoxic medication induced acute kidney injury in hospitalised non-critically ill children: single centre study
DOI:
https://doi.org/10.18203/2349-3933.ijam20252530Keywords:
Nephrotoxic medication exposure, Nephrotoxic acute kidney injury, Children, NINJA programAbstract
Background: Acute kidney injury (AKI) in children is increasingly linked to nephrotoxic medication exposure, particularly in hospitalized patients. Although nephrotoxic drugs contribute substantially to AKI incidence, especially with multiple-agent exposure, data on their prevalence and associated AKI risk in non-critically ill pediatric populations remain limited. This study assessed the prevalence of nephrotoxic medication exposure in non-critically ill children per 1000 patient-days of hospitalization, and the prevalence of nephrotoxic AKI among these patients.
Methods: This prospective study evaluated nephrotoxic medication exposure and the development of nephrotoxic AKI in non-critically ill hospitalized children aged 1 month to 12 years. Baseline kidney function was assessed and serum creatinine levels were monitored during and after the exposure period. AKI was defined according to KDIGO criteria. Upon AKI occurrence, nephrotoxic medications are substituted with less harmful alternatives.
Results: The study included 3,264 children with bronchopneumonia (29.4%), acute gastroenteritis (26%), and tropical fever (22.4%) as common hospitalization causes. Nephrotoxic medication exposure was identified in 3.1% of cases, yielding a prevalence rate of 5.02 per 1000 patient days. Most exposed children were aged 3 to 12 years (58.4%), with a nearly equal gender distribution (males: 51.5%). Among those exposed, 70.3% received one nephrotoxic medication, while 29.7% received two, resulting in an AKI prevalence of 5.94%. AKI resolved within an average of 11±4 days following the substitution of non-nephrotoxic drugs. The most frequently administered nephrotoxic drugs were vancomycin (38.6%), acyclovir (26.7%), and amikacin (17.8%).
Conclusions: The findings indicate that nephrotoxic medication exposure among non-critically ill children was minimal, with a low prevalence rate of nephrotoxic AKI. Vancomycin, acyclovir, and amikacin are the most commonly used nephrotoxic drugs.
Metrics
References
Goldstein SL, Devarajan P. Progression from acute kidney injury to chronic kidney disease: a pediatric perspective. Adv Chronic Kidney Dis. 2008;15:278-83. DOI: https://doi.org/10.1053/j.ackd.2008.04.007
Plötz FB, Bouma AB, van Wijk JAE, Kneyber MCJ, Bökenkamp A. Pediatric acute kidney injury in the ICU: an independent evaluation of pRIFLE criteria. Intensive Care Med. 2008;34:1713-7. DOI: https://doi.org/10.1007/s00134-008-1176-7
Askenazi DJ, Feig DI, Graham NM, Hui-Stickle S, Goldstein SL. 3-5 year longitudinal follow-up of pediatric patients after acute renal failure. Kidney Int. 2006;69(1):184-9. DOI: https://doi.org/10.1038/sj.ki.5000032
Hui-Stickle S, Brewer ED, Goldstein SL. Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis. 2005;45:96-101. DOI: https://doi.org/10.1053/j.ajkd.2004.09.028
Moghal NE, Brocklebank JT, Meadow SR. A review of acute renal failure in children: incidence, etiology and outcome. Clin Nephrol. 1998;49:91-5.
Williams DM, Sreedhar SS, Mickell JJ, Chan JCM. Acute kidney failure: a pediatric experience over 20 years. Arch Pediatr Adolesc Med. 2002;156:893-900. DOI: https://doi.org/10.1001/archpedi.156.9.893
Gouyon JB, Guignard JP. Management of acute renal failure in newborns. Pediatr Nephrol. 2000;14:1037-44. DOI: https://doi.org/10.1007/s004670050068
Mehta KP. Neonatal renal failure. Indian Pediatr. 1991;28:7-9.
Tóth-Heyn P, Drukker A, Guignard JP. The stressed neonatal kidney: from pathophysiology to clinical management of neonatal vasomotor nephropathy. Pediatr Nephrol. 2000;14:227-39. DOI: https://doi.org/10.1007/s004670050048
Bailey D, Phan V, Litalien C, Ducruet T, Mérouani A, Lacroix J, et al. Risk factors of acute renal failure in critically ill children: A prospective descriptive epidemiological study. Pediatr Crit Care Med. 2007;8(1):29-35. DOI: https://doi.org/10.1097/01.pcc.0000256612.40265.67
Goldstein SL, Dahale D, Kirkendall ES, Mottes T, Kaplan H, Muething S, et al. A prospective multi-center quality improvement initiative (NINJA) indicates a reduction in nephrotoxic acute kidney injury in hospitalized children. Kidney Int. 2020;97(3):580-8. DOI: https://doi.org/10.1016/j.kint.2019.10.015
Moffett BS, Goldstein SL. Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children. Clin J Am Soc Nephrol. 2011;6:856-63. DOI: https://doi.org/10.2215/CJN.08110910
Balduzzi A, Valsecchi MG, Silvestri D, Locatelli F, Manfredini L, Busca A, et al; Associazione Italiana Ematologia Oncologia Pediatrica-BMT Group. Transplant-related toxicity and mortality: an AIEOP prospective study in 636 pediatric patients transplanted for acute leukemia. Bone Marrow Transplant. 2002;29(2):93-100. DOI: https://doi.org/10.1038/sj.bmt.1703337
Askenazi DJ, Griffin R, McGwin G, Carlo W, Ambalavanan N. Acute kidney injury is independently associated with mortality in very low birth weight infants: a matched case-control analysis. Pediatr Nephrol. 2009;24:991-7. DOI: https://doi.org/10.1007/s00467-009-1133-x
Andreoli SP. Acute kidney injury in children. Pediatr Nephrol. 2008;24:253-63. DOI: https://doi.org/10.1007/s00467-008-1074-9
Zappitelli M, Parikh CR, Akcan-Arikan A, Washburn KK, Moffett BS, Goldstein SL. Ascertainment and epidemiology of acute kidney injury varies with definition interpretation. Clin J Am Soc Nephrol. 2008;3:948-54. DOI: https://doi.org/10.2215/CJN.05431207
Patzer L. Nephrotoxicity as a cause of acute kidney injury in children. Pediatr Nephrol. 2008;23:2159-73. DOI: https://doi.org/10.1007/s00467-007-0721-x
Almeida JP, João PRD, Sylvestre L de C. Impact of the use of nephrotoxic drugs in critically ill pediatric patients. Rev Bras Ter Intensiva. 2020;32:557-63. DOI: https://doi.org/10.5935/0103-507X.20200093
Downloads
Published
How to Cite
Issue
Section
